SIGN UP
LOG IN
G
GANX
Gain Therapeutics, Inc.
1.73
-0.07-3.89%After Hours: 1.830 +0.100 +5.78%19:56 06/13 EDT
OPEN/PREV CLOSE1.780/1.800
TODAY RANGE1.660-1.798
VOL221.05K
MARKET CAP51.13M
52 WEEK RANGE0.8900-3.190
AVG VOL (3M)274.42K
% TURNOVER0.75%
TURNOVER--
P/E (TTM)-1.9508
% RANGE7.65%
EPS(TTM)-0.8868
P/E(FORWARD)-2.5072
P/B8.60
BVPS0.2011
DIVIDEND--
P/S508.82
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP48.87M
SHARES OUTSTANDING29.56M
NEXT EARNINGS08/06-08/11
FREE FLOAT28.25M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·05/29 12:45
GAIN THERAPEUTICS ANNOUNCES ORAL PRESENTATION AT 2ND GBA1 MEETING
Benzinga·05/28 22:05
Gain Therapeutics Files For Mixed Shelf Offering Of $100M
Seeking Alpha·05/28 21:16
Gain Therapeutics announces $100M mixed shelf offering
TipRanks·05/28 21:05
Gain Therapeutics files $100M mixed securities shelf
Reuters·05/28 21:02
GAIN THERAPEUTICS: FILES FOR MIXED SHELF OFFERING OF $100 MLN - SEC FILING
TipRanks·05/15 12:00
Gain Therapeutics (GANX) Gets a Buy from Scotiabank
Benzinga·05/14 11:38
Gain Therapeutics Q1 EPS $(0.16) Beats $(0.18) Estimate
Dow Jones·05/14 11:32
*Gain Therapeutics 1Q-End Cash, Equivalents, Marketable Securities $9.1M >GANX
Dow Jones·05/14 11:30
Press Release: Gain Therapeutics Reports -2-
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.